105 related articles for article (PubMed ID: 16338222)
1. Short-term pioglitazone treatment prevents free fatty acid-induced hepatic insulin resistance in normal rats: possible role of the resistin and adiponectin.
Yang G; Li L; Tang Y; Boden G
Biochem Biophys Res Commun; 2006 Jan; 339(4):1190-6. PubMed ID: 16338222
[TBL] [Abstract][Full Text] [Related]
2. High-fat- and lipid-induced insulin resistance in rats: the comparison of glucose metabolism, plasma resistin and adiponectin levels.
Li L; Yang G; Li Q; Tang Y; Li K
Ann Nutr Metab; 2006; 50(6):499-505. PubMed ID: 17191023
[TBL] [Abstract][Full Text] [Related]
3. Effects of free fatty acids on plasma resistin and insulin resistance in awake rats.
Yang G; Li L; Fang C; Zhang L; Li Q; Tang Y; Boden G
Metabolism; 2005 Sep; 54(9):1142-6. PubMed ID: 16125524
[TBL] [Abstract][Full Text] [Related]
4. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients.
Bajaj M; Suraamornkul S; Hardies LJ; Pratipanawatr T; DeFronzo RA
Int J Obes Relat Metab Disord; 2004 Jun; 28(6):783-9. PubMed ID: 15024400
[TBL] [Abstract][Full Text] [Related]
5. The effect of pioglitazone on the liver: role of adiponectin.
Gastaldelli A; Miyazaki Y; Mahankali A; Berria R; Pettiti M; Buzzigoli E; Ferrannini E; DeFronzo RA
Diabetes Care; 2006 Oct; 29(10):2275-81. PubMed ID: 17003306
[TBL] [Abstract][Full Text] [Related]
6. [Effect of free fatty acid-induced insulin resistance on plasma ghrelin level: an experimental study with rats].
Li L; Yang GY
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1645-8. PubMed ID: 15569462
[TBL] [Abstract][Full Text] [Related]
7. Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver.
Ye JM; Frangioudakis G; Iglesias MA; Furler SM; Ellis B; Dzamko N; Cooney GJ; Kraegen EW
Endocrinology; 2002 Dec; 143(12):4527-35. PubMed ID: 12446579
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin is involved in the protective effect of DHEA against metabolic risk in aged rats.
Pérez-de-Heredia F; Sánchez J; Priego T; Nicolás F; Portillo Mdel P; Palou A; Zamora S; Garaulet M
Steroids; 2008 Oct; 73(11):1128-36. PubMed ID: 18534650
[TBL] [Abstract][Full Text] [Related]
9. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin and resistin response in the onset of obesity in male and female rats.
Ribot J; Rodríguez AM; Rodríguez E; Palou A
Obesity (Silver Spring); 2008 Apr; 16(4):723-30. PubMed ID: 18239591
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin--insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension.
Papadopoulos DP; Makris TK; Perrea D; Papazachou O; Daskalaki M; Sanidas E; Votteas V
Blood Press; 2008; 17(1):50-4. PubMed ID: 18568692
[TBL] [Abstract][Full Text] [Related]
12. Exenatide prevents fat-induced insulin resistance and raises adiponectin expression and plasma levels.
Li L; Yang G; Li Q; Tan X; Liu H; Tang Y; Boden G
Diabetes Obes Metab; 2008 Sep; 10(10):921-30. PubMed ID: 18093209
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin concentrations increase during acute FFA elevation in humans treated with rosiglitazone.
Krzyzanowska K; Mittermayer F; Krugluger W; Roden M; Schernthaner G; Wolzt M
Horm Metab Res; 2007 Oct; 39(10):769-72. PubMed ID: 17952842
[TBL] [Abstract][Full Text] [Related]
14. Association of resistin with visceral fat and muscle insulin resistance.
Borst SE; Conover CF; Bagby GJ
Cytokine; 2005 Oct; 32(1):39-44. PubMed ID: 16154759
[TBL] [Abstract][Full Text] [Related]
15. Alcohol intake modifies leptin, adiponectin and resistin serum levels and their mRNA expressions in adipose tissue of rats.
Pravdova E; Macho L; Fickova M
Endocr Regul; 2009 Jul; 43(3):117-25. PubMed ID: 19817506
[TBL] [Abstract][Full Text] [Related]
16. Relationship between changes in insulin sensitivity and associated cardiovascular disease risk factors in thiazolidinedione-treated, insulin-resistant, nondiabetic individuals: pioglitazone versus rosiglitazone.
Abbasi F; Lima NK; Reaven GM
Metabolism; 2009 Mar; 58(3):373-8. PubMed ID: 19217454
[TBL] [Abstract][Full Text] [Related]
17. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.
Dyck DJ; Heigenhauser GJ; Bruce CR
Acta Physiol (Oxf); 2006 Jan; 186(1):5-16. PubMed ID: 16497175
[TBL] [Abstract][Full Text] [Related]
18. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
[TBL] [Abstract][Full Text] [Related]
19. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.
Bajaj M; Suraamornkul S; Piper P; Hardies LJ; Glass L; Cersosimo E; Pratipanawatr T; Miyazaki Y; DeFronzo RA
J Clin Endocrinol Metab; 2004 Jan; 89(1):200-6. PubMed ID: 14715850
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]